Biggest News Aggregation in the World
📰 Chronic Sinusitis News

Chronic Sinusitis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Chronic Sinusitis. Real-time updates on events, politics, business and more.

OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript

OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript August 10, 2023 OptiNose, Inc. beats earnings expectations. Reported EPS is $0.02, expectations were $-0.11. Operator: Hello. Good day everyone and thank you for standing by. Welcome to the OptiNose Second Quarter 2023 Earnings Call. At this time, all participants are in a listen only mode. After […]
Lighthunter Shutterstock Jonathan Neely Ramy Mahmoud Forward Looking Statements Chronic Sinusitis Ramy Mahmoud
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Sinus Therapeutic Drugs Market is expected to reach US$ 6.35 billion by 2032

According to Future Market Insights (FMI), an ESOMAR-certified consultancy, the global Sinus Therapeutic Drugs Market size will reach US$ 6.35 billion by 2032, rising at a stable CAGR of 4% through 2032.One of the most important aspects driving the Sinus Therapeutic Drugs market is the introduction of biologics.Omal...
United States New York Regeneron Pharmaceuticals Inc Greater New York Chamber Drug Administration Market Insights Inc

Global Intranasal Drug Delivery Strategic Markets Report 2023-2030: Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era

/PRNewswire/ -- The "Intranasal Drug Delivery: Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering. Global Intranasal...
South Korea Laura Wood Age Group Glaxosmithkline Plc Peptide Drugs Available As Nasal Spray Solutions Astrazeneca Plc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science